148152-Thumbnail Image.png
Description

In the middle of the COVID-19 epidemic, flaws in the SARS-CoV-2 diagnostic<br/>test were identified by the impending supply shortages of nasopharyngeal swabs and nucleic acid isolation and purification kits. The

In the middle of the COVID-19 epidemic, flaws in the SARS-CoV-2 diagnostic<br/>test were identified by the impending supply shortages of nasopharyngeal swabs and nucleic acid isolation and purification kits. The ASU Biodesign Clinical Testing Lab (ABCTL), which converted from a research lab to SARS-CoV-2 testing lab, was not an exception to these shortages, but the consequences were greater due to its significant testing load in the state of Arizona.

620.44 KB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
  • 2021-05
Resource Type
  • Text
  • Machine-readable links